Jeffrey Michael Karp, Ph.D.
This page shows the publications co-authored by Jeffrey Karp and Vedagopuram Sreekanth.
A 3D culture platform enables development of zinc-binding prodrugs for targeted proliferation of ß cells. Sci Adv. 2020 11; 6(47).
Engineering designer beta cells with a CRISPR-Cas9 conjugation platform. Nat Commun. 2020 08 13; 11(1):4043.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.